Fact CheckerSign in

NCT06379880Completed

Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution

Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution: Prospective, Randomized, Multicenter Trial FEGALA

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

FEGALA is a comparative, multicenter, randomized, prospective, open-label study comparing the results observed at 3 months (± 15 days) on the EORTC QLQ-C30 scale in a group of patients with metastatic cancer followed on an outpatient basis and benefiting from the CONTINUUM+ CONNECT solution (with or without nursing support at home) versus comparable patients benefiting from conventional monitoring.

Status (registry)
Completed
Study type
Interventional
Enrollment
411 (actual)
First submitted
11 Apr 2024
Start date
25 Apr 2024
Primary completion date
7 Nov 2025
Lead sponsor
Centre Paul Strauss
NCT number
NCT06379880

What you commit to

  • Study type: Interventional
  • Participants enrolled: 411
  • From 25 Apr 2024 to the primary completion date, 7 Nov 2025
  • 13 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients receiving home hospitalization care or being hospitalized at the time of treatment initiation;
  • Patients receiving concomitant radiotherapy;

Other

  • Patients using another remote monitoring application;
  • Patients enrolled in another clinical trial;
  • Patients protected by law.

Who the study is looking for

  • Adult patients aged ≥ 18 years with a solid tumor (only breast, lung, colorectal, prostate cancer) at the metastatic stage followed on an outpatient basis;
  • Patients initiating oral and/or injectable anticancer treatment, whatever the line of treatment, administered on an outpatient basis including day hospitalization;
  • Patients who have given their written, free and informed consent;
  • Patients with life expectancy of more than 3 months;
  • Patients able to complete questionnaires according to the investigator's judgment, and to use the CONTINUUM+ CONNECT electronic application either alone or accompanied by a professional (home nurse);
  • Patients affiliated to a social security scheme or beneficiaries of such a scheme.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (13)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sainte Catherine Institut du Cancer Avignon Provence
Coordinator of this site? Confirm its status
AvignonFranceUnknown status
Polyclinique de Blois
Coordinator of this site? Confirm its status
BloisFranceUnknown status
Pôle Santé République
Coordinator of this site? Confirm its status
Clermont-FerrandFranceUnknown status
Centre Georges François Leclerc
Coordinator of this site? Confirm its status
DijonFranceUnknown status
Chu Dupuytren
Coordinator of this site? Confirm its status
LimogesFranceUnknown status
Centre Hospitalier de Morlaix
Coordinator of this site? Confirm its status
MorlaixFranceUnknown status
Centre d Oncologie de Gentilly
Coordinator of this site? Confirm its status
NancyFranceUnknown status
Hôpitla privé des Côtes d'Armor - Centre CARIO-HPCA
Coordinator of this site? Confirm its status
PlérinFranceUnknown status
Institut Jean Godinot
Coordinator of this site? Confirm its status
ReimsFranceUnknown status
Chu de Saint Etienne
Coordinator of this site? Confirm its status
Saint-Priest-en-JarezFranceUnknown status
Centre Paul Strauss
Coordinator of this site? Confirm its status
StrasbourgFranceUnknown status
Hopitaux Universitaires de Strasbourg
Coordinator of this site? Confirm its status
StrasbourgFranceUnknown status
Institut de Cancérologie de Lorraine
Coordinator of this site? Confirm its status
Vandœuvre-lès-NancyFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.